scholarly article | Q13442814 |
P2093 | author name string | Jung-Joon Min | |
Yeongjin Hong | |||
Hyon E Choy | |||
Hyung-Seok Kim | |||
Seung-Hwan Park | |||
Misun Yun | |||
Vu Hong Nguyen | |||
Sheng-Nan Jiang | |||
Che-Hun Jung | |||
SangO Pan | |||
P2860 | cites work | Quantitative bioluminescence imaging of tumor-targeting bacteria in living animals | Q47794539 |
Construction of VNP20009: a novel, genetically stable antibiotic-sensitive strain of tumor-targeting Salmonella for parenteral administration in humans | Q50102062 | ||
Tumor-targeted Salmonella as a novel anticancer vector | Q50133173 | ||
Assay of proteins in the presence of interfering materials | Q67442036 | ||
Selective localization and growth of Bifidobacterium bifidum in mouse tumors following intravenous administration | Q72132396 | ||
A novel src homology 3 domain-containing adaptor protein, HIP-55, that interacts with hematopoietic progenitor kinase 1 | Q22010811 | ||
Organization of the hTMnm gene. Implications for the evolution of muscle and non-muscle tropomyosins | Q24298463 | ||
HIP-55 is important for T-cell proliferation, cytokine production, and immune responses | Q24529866 | ||
Can engineered bacteria help control cancer? | Q24555059 | ||
Hemopexin: structure, function, and regulation | Q28202032 | ||
Orchestration of iron homeostasis | Q28247349 | ||
Intermediate filaments: structure, dynamics, function, and disease | Q29615442 | ||
Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma | Q33340438 | ||
Biological functions of haptoglobin--new pieces to an old puzzle | Q33368325 | ||
Tumor invasion of Salmonella enterica serovar Typhimurium is accompanied by strong hemorrhage promoted by TNF-alpha | Q33495169 | ||
Molecular imaging of biological gene delivery vehicles for targeted cancer therapy: beyond viral vectors | Q33704231 | ||
Inhibition of tumor growth and metastasis by a combination of Escherichia coli-mediated cytolytic therapy and radiotherapy | Q33731187 | ||
Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium | Q33756746 | ||
The role of the vimentin intermediate filaments in rat 3Y1 cells elucidated by immunoelectron microscopy and computer-graphic reconstruction | Q34028595 | ||
DNA repair targeting and radiotherapy: a focus on the therapeutic ratio | Q34137280 | ||
Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins | Q34301980 | ||
Transferrin and the transferrin receptor: of magic bullets and other concerns. | Q34778137 | ||
Bacterial iron sources: from siderophores to hemophores | Q35919884 | ||
Use of bacteria in anti-cancer therapies | Q36348880 | ||
Sample preparation by in-gel digestion for mass spectrometry-based proteomics | Q36885907 | ||
Engineering the perfect (bacterial) cancer therapy | Q37131536 | ||
Hemoglobin and heme scavenger receptors. | Q37573795 | ||
Bacteriolytic therapy can generate a potent immune response against experimental tumors | Q37585498 | ||
Targeting solid tumors with non-pathogenic obligate anaerobic bacteria | Q37767742 | ||
Noninvasive real-time imaging of tumors and metastases using tumor-targeting light-emitting Escherichia coli | Q38503600 | ||
Genetically engineered Salmonella typhimurium as an imageable therapeutic probe for cancer | Q39760012 | ||
Colonization of experimental murine breast tumours by Escherichia coli K-12 significantly alters the tumour microenvironment | Q40022374 | ||
Systemic administration of an attenuated, tumor-targeting Salmonella typhimurium to dogs with spontaneous neoplasia: phase I evaluation | Q40504400 | ||
ppGpp-dependent stationary phase induction of genes on Salmonella pathogenicity island 1. | Q40552048 | ||
Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice | Q43677697 | ||
Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors | Q45882843 | ||
Immune response induced by Salmonella typhimurium defective in ppGpp synthesis | Q46852567 | ||
P433 | issue | 3 | |
P304 | page(s) | 502-510 | |
P577 | publication date | 2012-06-30 | |
P1433 | published in | The Journal of Microbiology | Q15749838 |
P1476 | title | Effect of Salmonella treatment on an implanted tumor (CT26) in a mouse model | |
P478 | volume | 50 |
Q57300412 | Cancer Immunotherapy: Priming the Host Immune Response with Live Attenuated |
Q40163572 | Local application of bacteria improves safety of Salmonella -mediated tumor therapy and retains advantages of systemic infection. |
Q90618645 | Salmonella-Mediated Cancer Therapy: An Innovative Therapeutic Strategy |
Q39339432 | Salmonella-Mediated Cancer Therapy: Roles and Potential |
Q37225613 | Therapy of solid tumors using probiotic Symbioflor-2: restraints and potential |
Q40108146 | Tumour-targeting bacteria-based cancer therapies for increased specificity and improved outcome. |
Search more.